Quote | PolyPid Ltd. (NASDAQ:PYPD)
Last: | $4.7525 |
---|---|
Change Percent: | -1.94% |
Open: | $4.8999 |
Close: | $4.7525 |
High: | $4.8999 |
Low: | $4.7486 |
Volume: | 2,320 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | PolyPid Ltd. (NASDAQ:PYPD)
2023-05-10 07:25:24 ET PolyPid press release ( NASDAQ: PYPD ): Q1 GAAP EPS of $0.28 beats by $0.56 . As of March 31, 2023, the Company had cash and cash equivalents and deposits in the amount of $13.4 million, Research and development (R&D) expenses f...
Submitted Revised Protocol for SHIELD II Phase 3 Trial to FDA to Evaluate D-PLEX 100 for Prevention of Abdominal Colorectal Surgical Site Infections ; Recruitment Expected to Re sume Imminently Received Advice from the Swedish Medical Prod...
Message Board Posts | PolyPid Ltd. (NASDAQ:PYPD)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
PolyPid Ltd. Company Name:
PYPD Stock Symbol:
NASDAQ Market:
PETACH TIKVA, Israel, April 24, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (NASDAQ:PYPD) ("PolyPid" or the "Company"), a late-stage biopharma compa...
PETACH TIKVA, Israel, Feb. 28, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (NASDAQ:PYPD), ("PolyPid" or the "Company"), a late-stage biopharma compa...
PETACH TIKVA, Israel, Jan. 31, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (NASDAQ:PYPD) ("PolyPid" or the "Company"), a late-stage biopharma compan...